Sam Brusco, Associate Editor01.19.24
Dexcom announced that it has broken ground on a new manufacturing facility in Athenry, Co. Galway. The company said the new facility should bring over 1,000 jobs to the area.
The 1,000 available jobs include support in finance, human resources, and engineering roles ranging from leadership to graduate positions. Dexcom intends to build relationships with the local universities in Galway and nearby counties, with focus on engineering and quality assurance roles.
The company’s first manufacturing facility in Europe will have the capacity to produce millions of Dexcom rtCGM (real-time continuous glucose monitoring) sensors each year.
“This facility is strategically located in Europe, for Europe,” said Alex Moussa, senior VP and GM of EMEA and LATAM at Dexcom. “This development demonstrates our commitment to sustainable growth and operational excellence in EMEA, as well as to the people we serve. This is only the beginning; we’re truly excited for what’s to come.”
The company also announced a 12-year naming rights partnership with Connacht Rugby. “The Sportsground,” Connacht Rugby’s home since 1927, will now be known as “Dexcom Stadium.”
“At Dexcom, we pride ourselves on attracting and retaining world-class talent, which Ireland provides,” said Simone Würzner, senior director human resources EMEA. “As an organization, we empower people to better manage their health with our life-changing continuous glucose monitoring technology. The opportunity this provides to our team is endless, offering challenging and meaningful work that truly makes a difference in people’s lives. We’re looking forward to building our team in Ireland as we enter the next phase of Dexcom in Europe.”
Earlier this month, Dexcom submitted its Stelo glucose sensor for non-insulin users to the U.S. Food and Drug Administration (FDA).
The 1,000 available jobs include support in finance, human resources, and engineering roles ranging from leadership to graduate positions. Dexcom intends to build relationships with the local universities in Galway and nearby counties, with focus on engineering and quality assurance roles.
The company’s first manufacturing facility in Europe will have the capacity to produce millions of Dexcom rtCGM (real-time continuous glucose monitoring) sensors each year.
“This facility is strategically located in Europe, for Europe,” said Alex Moussa, senior VP and GM of EMEA and LATAM at Dexcom. “This development demonstrates our commitment to sustainable growth and operational excellence in EMEA, as well as to the people we serve. This is only the beginning; we’re truly excited for what’s to come.”
The company also announced a 12-year naming rights partnership with Connacht Rugby. “The Sportsground,” Connacht Rugby’s home since 1927, will now be known as “Dexcom Stadium.”
“At Dexcom, we pride ourselves on attracting and retaining world-class talent, which Ireland provides,” said Simone Würzner, senior director human resources EMEA. “As an organization, we empower people to better manage their health with our life-changing continuous glucose monitoring technology. The opportunity this provides to our team is endless, offering challenging and meaningful work that truly makes a difference in people’s lives. We’re looking forward to building our team in Ireland as we enter the next phase of Dexcom in Europe.”
Earlier this month, Dexcom submitted its Stelo glucose sensor for non-insulin users to the U.S. Food and Drug Administration (FDA).